comparemela.com
  1. Home
  2. Live Updates
  3. Has Significant Unmet Need - Breaking News

Latest Breaking News On - Has significant unmet need - Page 1 : comparemela.com

Windtree: Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024

Windtree: Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Matt epsteinStefan klotterAli hajiluyiWindtree therapeutics incWindtree therapeuticsShock requires urgent medical treatmentHas significant unmet needExtension studyLassen sie

Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024

19.12.2023 - WARRINGTON, PA / ACCESSWIRE / December 19, 2023 / Windtree Therapeutics, Inc. (NASDAQ:WINT) has recently enrolled the first subject in its phase 2 SEISMiC Extension Study to evaluate istaroxime in the treatment of early cardiogenic shock. The phase .

Ali hajiluyiHas significant unmet needExtension study

Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock

Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock .

News networkWindtree therapeutics incWindtree therapeuticsShock requires urgent medical treatmentHas significant unmet needDrug treatmentExtension studyAli hajiluyi

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.